Artwork

Content provided by MediCom Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MediCom Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How does the safety profile of the new and emerging anti-PD 1 antibodies differ from chemotherapy?

1:55
 
Share
 

Manage episode 182688939 series 1375096
Content provided by MediCom Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MediCom Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Listen as Dr. Alison Moskowitz discusses the safety profile of the new and emerging anti-PD1 antibodies and how this differs from traditional chemotherapy in just under two minutes.
  continue reading

53 episodes

Artwork
iconShare
 
Manage episode 182688939 series 1375096
Content provided by MediCom Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MediCom Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Listen as Dr. Alison Moskowitz discusses the safety profile of the new and emerging anti-PD1 antibodies and how this differs from traditional chemotherapy in just under two minutes.
  continue reading

53 episodes

所有剧集

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide